Get the Stockscreener App
5.10
8.44%
-0.47
Rezolute Inc Stock (RZLT) Latest News
Rezolute (NASDAQ:RZLT) Upgraded at Craig Hallum - Defense World
RZLT Shares Rise 30.8% in 6 Months: What's Driving the Rally? - MSN
What is the investor’s view on Rezolute Inc (RZLT)? - US Post News
Rezolute (NASDAQ:RZLT) Rating Increased to Strong-Buy at Craig Hallum - MarketBeat
The Attractiveness of Investing In Rezolute Inc (RZLT) is Growing - Knox Daily
H.C. Wainwright reiterates Buy on Rezolute shares, $14 target - Investing.com India
Rezolute (NASDAQ:RZLT) Given "Buy" Rating at HC Wainwright - MarketBeat
JPMorgan Chase & Co. Purchases New Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute Advances SunRIZE Study for Hypoglycemia Treatment - TipRanks
Rezolute's ersodetug advances in pediatric study - MSN
Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism - Marketscreener.com
Clinical Trial Breakthrough: Rezolute's Rare Disease Drug Shows Promise in Vulnerable Infant Population - StockTitan
Rezolute (RZLT) Projected to Post Earnings on Tuesday - MarketBeat
Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference -February 03, 2025 at 09:06 am EST - Marketscreener.com
(RZLT) Trading Report - Stock Traders Daily
Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference - The Manila Times
Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference -January 31, 2025 at 08:01 am EST - Marketscreener.com
Rare Disease Pioneer Rezolute Takes Center Stage at Elite Guggenheim Biotech Conference - StockTitan
Rezolute receives breakthrough therapy designation for treatment of hypoglycemia - MSN
Cantor Fitzgerald Predicts Rezolute FY2025 Earnings - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives $24.13 Average Target Price from Analysts - Defense World
Brokerages Set Rezolute, Inc. (NASDAQ:RZLT) Price Target at $24.13 - MarketBeat
Rezolute shares Phase 2 clinical study update By Investing.com - Investing.com South Africa
Rezolute shares Phase 2 clinical study update - Investing.com
Rezolute Highlights Promising Phase 2 Ersodetug Results - TipRanks
(RZLT) On The My Stocks Page - Stock Traders Daily
Top 5 Small-cap Biotech Stocks (Updated January 2025) - Investing News Network
Rezolute, Inc. (NASDAQ:RZLT) Shares Acquired by Geode Capital Management LLC - MarketBeat
Rezolute Gains FDA Breakthrough Designation for Ersodetug - TipRanks
Here's Why 'Trend' Investors Would Love Betting on Rezolute (RZLT) - Yahoo Finance
FDA Grants Breakthrough Therapy Status to Rezolute's Ersodetug for Congenital Hyperinsulinism - StockTitan
State Street Corp Acquires 13,000 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Resolute Mining (LON:RSG) Stock Price Down 4.1% – Time to Sell? - Defense World
CompoSecure to Spin-Off Resolute Holdings Management - citybiz
CompoSecure Announces Strategic Spin-Off of Resolute Holdings Management, Targets Asset Management Growth - StockTitan
MML Investors Services LLC Makes New $57,000 Investment in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying - Yahoo Finance
Brokerages Set Rezolute, Inc. (NASDAQ:RZLT) Target Price at $24.13 - Defense World
Rezolute, Inc. (NASDAQ:RZLT) Given Average Rating of "Buy" by Analysts - MarketBeat
Rezolute CFO Daron Evans buys $42,900 in company stock By Investing.com - Investing.com Australia
Rezolute CFO Daron Evans buys $42,900 in company stock - Investing.com India
Insider Buying: Rezolute, Inc. (NASDAQ:RZLT) CFO Buys 10,000 Shares of Stock - MarketBeat
Rezolute's SWOT analysis: biotech stock's pipeline progress and market potential - Investing.com Nigeria
Rezolute's SWOT analysis: biotech stock's pipeline progress and market potential By Investing.com - Investing.com South Africa
Chief Financial Officer of Rezolute Daron Evans Buys 6.5% More Shares - Simply Wall St
Rezolute (NASDAQ:RZLT) and BetterLife Pharma (OTCMKTS:PVOTF) Head to Head Comparison - Defense World
When the Price of (RZLT) Talks, People Listen - Stock Traders Daily
Rezolute expands authorized shares following shareholder approval - Investing.com
Daron Evans, CFO of Rezolute, buys $53,166 in common shares By Investing.com - Investing.com Nigeria
Daron Evans, CFO of Rezolute, buys $53,166 in common shares - Investing.com
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):